Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-010563-17Phase 4Active
Phase 4, single-arm trial of fluticasone in exercise-induced bronchospasm (EIB), allergic rhinitis (AR) and allergic asthma, sponsored by Stichting Pediatrisch Onderzoek Enschede. Primary endpoint: Reduction in exercise-induced fall of FEV1. Started Feb 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-010563-17.